. Author manuscript; available in PMC: 2015 May 1.

Published in final edited form as: Acta Neuropathol. 2014 Jan 3;127(5):621–632. doi: 10.1007/s00401-013-1236-0

Table 1.

Characteristics of the ADNI subjects studied here.

	CN (n=92)	MCI (n=149)	AD (n=69)	p-value
Age at baseline (years)^*	75.7 (5.4)	74.8 (7.2)	75.0 (7.7)	0.61
Gender (% male)	50%	64.5%	57.0%	0.0070
Education (years)^*	15.6 (2.9)	16.0 (2.9)	15.1 (2.9)	0.14
APOE ε4 presence (%)	22 (23.9%)	80 (53.7%)	49 (71.0%)	<0.0001
ADAS^*	9.4(4.2)	19.2 (6.1)	29.1 (8.3)	<0.0001
APOE CSF levels (µg/ml)^†	6.9 (6.1–8.5)	7.2 (5.4–8.5)	6.1 (4.8–8.0)	0.065
Aβ_1–42 (pg/ml)^†	220.0 (161.0–252.5)	144.0 (126.0–185.5)	134.0 (122.0–162.0)	<0.0001
T-tau (pg/ml)^†	61.0 (48.0–84.5)	87.0 (65.0–121.5)	116.0 (81.0–157.8)	<0.0001
P-tau₁₈₁ (pg/ml)^†	20.0 (16.5–29.5)	35.5 (23.0–46.3)	36.0 (29.0–49.0)	<0.0001

Mean (standard deviation);

^†

Median (1^st quartile-3^rd quartile).